Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Cardiac troponin T and NT-proBNP as biomarkers of early myocardial damage in amitriptyline-induced cardiovascular toxicity in rats.

Sorodoc V, Sorodoc L, Ungureanu D, Sava A, Jaba IM.

Int J Toxicol. 2013 Sep-Oct;32(5):351-7. doi: 10.1177/1091581813503888. Epub 2013 Sep 20.

PMID:
24055824
2.

Assessment of anthracycline-induced cardiotoxicity with biochemical markers.

Horacek JM, Pudil R, Jebavy L, Tichy M, Zak P, Maly J.

Exp Oncol. 2007 Dec;29(4):309-13.

PMID:
18199989
3.

The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.

Horácek JM, Pudil R, Tichý M, Jebavý L, Strasová A, Praus R, Zák P, Malý J.

Neoplasma. 2005;52(5):430-4.

PMID:
16151589
4.

Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.

Perna ER, Macin SM, Cimbaro Canella JP, Szyszko A, Franciosi V, Vargas Morales W, Bayol AP, Kriskovich JO, Medina F, Gonzalez Arjol B, Brizuela M.

J Heart Lung Transplant. 2006 Oct;25(10):1230-40.

PMID:
17045936
5.

Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.

Horacek JM, Pudil R, Tichy M, Jebavy L, Zak P, Slovacek L, Maly J.

Exp Oncol. 2007 Sep;29(3):243-7.

PMID:
18004253
7.

Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.

Gravning J, Smedsrud MK, Omland T, Eek C, Skulstad H, Aaberge L, Bendz B, Kjekshus J, Mørkrid L, Edvardsen T.

Am Heart J. 2013 May;165(5):716-24. doi: 10.1016/j.ahj.2013.02.008. Epub 2013 Mar 26.

PMID:
23622908
8.

Cardiac biomarkers are influenced by dialysis characteristics.

Sommerer C, Heckele S, Schwenger V, Katus HA, Giannitsis E, Zeier M.

Clin Nephrol. 2007 Dec;68(6):392-400.

PMID:
18184522
9.

Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.

Alehagen U, Dahlström U, Rehfeld JF, Goetze JP.

Clin Chem. 2010 Nov;56(11):1718-24. doi: 10.1373/clinchem.2009.141341. Epub 2010 Sep 15.

10.

Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population.

Xu R, Ye P, Luo L, Sheng L, Wu H, Xiao W, Zheng J, Wang F, Xiao T.

Chin Med J (Engl). 2014;127(4):638-44.

PMID:
24534215
11.

NT-proBNP as a biomarker for the assessment of a potential cardiovascular drug-induced liability in beagle dogs.

Crivellente F, Tontodonati M, Fasdelli N, Casartelli A, Dorigatti R, Faustinelli I, Cristofori P.

Cell Biol Toxicol. 2011 Dec;27(6):425-38. doi: 10.1007/s10565-011-9197-3. Epub 2011 Aug 8.

PMID:
21823034
13.

The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.

Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.

Anesth Analg. 2009 Nov;109(5):1403-8. doi: 10.1213/ANE.0b013e3181b893dd.

PMID:
19843778
14.

Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.

de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A.

Am Heart J. 2012 May;163(5):821-8. doi: 10.1016/j.ahj.2012.03.004.

PMID:
22607860
15.

Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise.

Scharhag J, Herrmann M, Urhausen A, Haschke M, Herrmann W, Kindermann W.

Am Heart J. 2005 Dec;150(6):1128-34.

PMID:
16338248
16.

Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.

Neeland IJ, Drazner MH, Berry JD, Ayers CR, deFilippi C, Seliger SL, Nambi V, McGuire DK, Omland T, de Lemos JA.

J Am Coll Cardiol. 2013 Jan 15;61(2):187-95. doi: 10.1016/j.jacc.2012.10.012. Epub 2012 Dec 5.

17.

N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.

Jernberg T, Lindahl B, Siegbahn A, Andren B, Frostfeldt G, Lagerqvist B, Stridsberg M, Venge P, Wallentin L.

J Am Coll Cardiol. 2003 Dec 3;42(11):1909-16.

18.

Long-term cardiac effects of treatment for childhood leukemia.

Urbanova D, Urban L, Simkova I, Danova K, Mikuskova E, Mladosievicova B.

Neoplasma. 2010;57(2):179-83.

PMID:
20099983
19.

Combined measurement of N-terminal pro-B-type natriuretic peptide and highly sensitive cardiac troponin T for diagnosis and monitoring of heart injury in chronic Chagas' disease.

Munoz Saravia SG, Haberland A, Bartel S, Araujo R, Valda G, Reynaga DD, Ramirez ID, Borges AC, Wallukat G, Ziebig R, Schimke I.

Clin Biochem. 2013 Oct;46(15):1615-8. doi: 10.1016/j.clinbiochem.2013.06.011. Epub 2013 Jun 27.

PMID:
23810852
20.

Combined measurements of cardiac troponin T and N-terminal pro-brain natriuretic peptide in patients with heart failure.

Taniguchi R, Sato Y, Yamada T, Ooba M, Higuchi H, Matsumori A, Kimura T, Kita T.

Circ J. 2004 Dec;68(12):1160-4.

Supplemental Content

Support Center